Skip to main content

J&J To Pay $117M To Settle 41 States Mesh Lawsuit

J&J To Pay $117M To Settle 41 States Mesh Lawsuit

J&J To Pay $117M To Settle 41 States Mesh Lawsuit

Introduction

On Thursday, New York Attorney General Letitia James and 41 other state AGs resolved the transvaginal mesh lawsuit involving J&J (Johnson & Johnson) and their subsidiary Ethicon, Inc. for $117 million.

The defendants were facing allegations for hiding the risks associated with its pelvic mesh products, which support women's weakening pelvic organs. The court papers further stated that the companies should now impart the irreversible risks including, chronic pain,  inflammation, incontinence, painful sex, and scarring. The defendants are also barred from telling about its FDA approval, which was initially done in 2002, and now has been told to stop selling “due to safety concerns.”

Around four million women have vaginal mesh implants, and more than 150,000 developed complications associated with it. There are in all 7 MDLs to handle Transvaginal Mesh Litigations, which are being overseen by U.S. District Judge Joseph R. Goodwin.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients

A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…

FDA Adds New Warnings on Long-Term Opioid Risks

Categories: Opioids

Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!